25 XP   0   0   10

Biofrontera Inc
Buy, Hold or Sell?

Let's analyse Biofrontera Inc together

PenkeI guess you are interested in Biofrontera Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biofrontera Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biofrontera Inc

I send you an email if I find something interesting about Biofrontera Inc.

Quick analysis of Biofrontera Inc (30 sec.)










What can you expect buying and holding a share of Biofrontera Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.20
Expected worth in 1 year
$-4.03
How sure are you?
46.2%

+ What do you gain per year?

Total Gains per Share
$-4.24
Return On Investment
-368.3%

For what price can you sell your share?

Current Price per Share
$1.15
Expected price per share
$0.61 - $2.66
How sure are you?
50%

1. Valuation of Biofrontera Inc (5 min.)




Live pricePrice per Share (EOD)

$1.15

Intrinsic Value Per Share

$-42.00 - $-48.77

Total Value Per Share

$-41.79 - $-48.56

2. Growth of Biofrontera Inc (5 min.)




Is Biofrontera Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$1m$15.6m-$3.4m-28.0%

How much money is Biofrontera Inc making?

Current yearPrevious yearGrowGrow %
Making money-$6.6m-$6.1m-$483k-7.3%
Net Profit Margin-88.2%-54.3%--

How much money comes from the company's main activities?

3. Financial Health of Biofrontera Inc (5 min.)




What can you expect buying and holding a share of Biofrontera Inc? (5 min.)

Welcome investor! Biofrontera Inc's management wants to use your money to grow the business. In return you get a share of Biofrontera Inc.

What can you expect buying and holding a share of Biofrontera Inc?

First you should know what it really means to hold a share of Biofrontera Inc. And how you can make/lose money.

Speculation

The Price per Share of Biofrontera Inc is $1.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biofrontera Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biofrontera Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.20. Based on the TTM, the Book Value Change Per Share is $-1.06 per quarter. Based on the YOY, the Book Value Change Per Share is $1.96 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biofrontera Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-1.25-108.4%-1.41-123.0%-0.11-9.3%-0.89-77.2%-0.89-77.2%
Usd Book Value Change Per Share-1.21-104.8%-1.06-92.1%1.96170.8%0.021.4%0.021.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-1.21-104.8%-1.06-92.1%1.96170.8%0.021.4%0.021.4%
Usd Price Per Share8.77-2.70-3.44-1.89-1.89-
Price to Earnings Ratio-1.76--0.58--1.19--0.54--0.54-
Price-to-Total Gains Ratio-7.28--1.09-1.64-0.28-0.28-
Price to Book Ratio43.00-10.94-3.41-4.41-4.41-
Price-to-Total Gains Ratio-7.28--1.09-1.64-0.28-0.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.15
Number of shares869
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-1.060.02
Usd Total Gains Per Share-1.060.02
Gains per Quarter (869 shares)-920.2013.63
Gains per Year (869 shares)-3,680.7954.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3681-369105545
20-7362-73720109100
30-11042-110530164155
40-14723-147340218210
50-18404-184150273265
60-22085-220960327320
70-25766-257770382375
80-29446-294580436430
90-33127-331390491485
100-36808-368200545540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.012.00.07.7%1.012.00.07.7%1.012.00.07.7%
Book Value Change Per Share1.03.00.025.0%6.05.01.050.0%6.05.02.046.2%6.05.02.046.2%6.05.02.046.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.013.00.0%0.00.013.00.0%0.00.013.00.0%
Total Gains per Share1.03.00.025.0%6.05.01.050.0%6.05.02.046.2%6.05.02.046.2%6.05.02.046.2%

Fundamentals of Biofrontera Inc

About Biofrontera Inc

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-09 17:52:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biofrontera Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biofrontera Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -71.4% means that $-0.71 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biofrontera Inc:

  • The MRQ is -71.4%. The company is making a huge loss. -2
  • The TTM is -88.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-71.4%TTM-88.2%+16.8%
TTM-88.2%YOY-54.3%-33.9%
TTM-88.2%5Y-90.0%+1.9%
5Y-90.0%10Y-90.0%0.0%
1.1.2. Return on Assets

Shows how efficient Biofrontera Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -18.6% Return on Assets means that Biofrontera Inc generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biofrontera Inc:

  • The MRQ is -18.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-18.6%TTM-17.1%-1.5%
TTM-17.1%YOY-11.5%-5.6%
TTM-17.1%5Y-19.6%+2.5%
5Y-19.6%10Y-19.6%0.0%
1.1.3. Return on Equity

Shows how efficient Biofrontera Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -611.0% Return on Equity means Biofrontera Inc generated $-6.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biofrontera Inc:

  • The MRQ is -611.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -201.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-611.0%TTM-201.1%-409.9%
TTM-201.1%YOY-56.6%-144.6%
TTM-201.1%5Y-84.2%-116.9%
5Y-84.2%10Y-84.2%0.0%

1.2. Operating Efficiency of Biofrontera Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biofrontera Inc is operating .

  • Measures how much profit Biofrontera Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -54.9% means the company generated $-0.55  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biofrontera Inc:

  • The MRQ is -54.9%. The company is operating very inefficient. -2
  • The TTM is -79.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-54.9%TTM-79.4%+24.5%
TTM-79.4%YOY-105.5%+26.1%
TTM-79.4%5Y-95.7%+16.3%
5Y-95.7%10Y-95.7%0.0%
1.2.2. Operating Ratio

Measures how efficient Biofrontera Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are $1.52 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biofrontera Inc:

  • The MRQ is 1.522. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.792. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.522TTM1.792-0.270
TTM1.792YOY2.189-0.397
TTM1.7925Y2.012-0.221
5Y2.01210Y2.0120.000

1.3. Liquidity of Biofrontera Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biofrontera Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.02 means the company has $1.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biofrontera Inc:

  • The MRQ is 1.017. The company is just able to pay all its short-term debts.
  • The TTM is 1.544. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.017TTM1.544-0.527
TTM1.544YOY3.174-1.630
TTM1.5445Y2.751-1.207
5Y2.75110Y2.7510.000
1.3.2. Quick Ratio

Measures if Biofrontera Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.57 means the company can pay off $0.57 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biofrontera Inc:

  • The MRQ is 0.570. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 1.359. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ0.570TTM1.359-0.788
TTM1.359YOY1.936-0.577
TTM1.3595Y1.423-0.064
5Y1.42310Y1.4230.000

1.4. Solvency of Biofrontera Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biofrontera Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biofrontera Inc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.97 means that Biofrontera Inc assets are financed with 97.0% credit (debt) and the remaining percentage (100% - 97.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biofrontera Inc:

  • The MRQ is 0.970. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.727. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.970TTM0.727+0.243
TTM0.727YOY0.711+0.016
TTM0.7275Y0.806-0.079
5Y0.80610Y0.8060.000
1.4.2. Debt to Equity Ratio

Measures if Biofrontera Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 3,185.5% means that company has $31.86 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biofrontera Inc:

  • The MRQ is 31.855. The company is unable to pay all its debts with equity. -1
  • The TTM is 9.659. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ31.855TTM9.659+22.196
TTM9.659YOY2.734+6.925
TTM9.6595Y4.297+5.363
5Y4.29710Y4.2970.000

2. Market Valuation of Biofrontera Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biofrontera Inc generates.

  • Above 15 is considered overpriced but always compare Biofrontera Inc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.76 means the investor is paying $-1.76 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biofrontera Inc:

  • The EOD is -0.231. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.759. Based on the earnings, the company is expensive. -2
  • The TTM is -0.581. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.231MRQ-1.759+1.529
MRQ-1.759TTM-0.581-1.178
TTM-0.581YOY-1.190+0.609
TTM-0.5815Y-0.545-0.036
5Y-0.54510Y-0.5450.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biofrontera Inc:

  • The EOD is -0.730. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.568. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.496. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.730MRQ-5.568+4.838
MRQ-5.568TTM-1.496-4.072
TTM-1.496YOY5.805-7.300
TTM-1.4965Y1.326-2.822
5Y1.32610Y1.3260.000
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biofrontera Inc is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Biofrontera Inc:

  • The EOD is 5.639. Based on the equity, the company is overpriced. -1
  • The MRQ is 43.000. Based on the equity, the company is expensive. -2
  • The TTM is 10.937. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD5.639MRQ43.000-37.362
MRQ43.000TTM10.937+32.063
TTM10.937YOY3.406+7.531
TTM10.9375Y4.413+6.524
5Y4.41310Y4.4130.000
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biofrontera Inc.

3.1. Institutions holding Biofrontera Inc

Institutions are holding 14.392% of the shares of Biofrontera Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Vanguard Group Inc0.2152010954109540
2023-12-31BlackRock Inc0.09080462200
2023-09-30Advisor Group Holdings, Inc.0.01206096090
2023-09-30Royal Bank of Canada0.0002011110
2023-09-30Wells Fargo & Co0.00010660
2023-09-30JPMorgan Chase & Co00110
2023-09-30UBS Group AG00110
Total 0.3183016204+11582+71.5%

3.2. Funds holding Biofrontera Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.51120861100
2023-12-31Fidelity Extended Market Index0.25250425400
2023-12-31Fidelity Series Total Market Index0.0585098500
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0379063800
2023-12-31Fidelity Nasdaq Composite Index0.0324054600
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0304051210.1957
2023-12-31Fidelity Total Market Index0.0251042200
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0237039900
2023-12-31Northern Trust Extended Eq Market Idx0.0237039900
2023-12-31Spartan Total Market Index Pool E0.0116019600
2024-01-31State St US Extended Mkt Indx NL Cl C0.004708000
2023-12-31SSgA U.S. Extended Market Index Class I0.004708000
2024-01-31State St US Ttl Mkt Indx SL Cl I0.003305500
2023-12-31SSgA U.S. Total Market Index Strategy0.0014023-1-4.1667
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.001202100
2023-09-30BlackRock Extended Mkt Composite0.000509112.5
2023-12-31BlackRock Extended Equity Market K0.00050800
2023-12-31Extended Equity Market Fund M0.00010100
Total 1.0234017239+1+0.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biofrontera Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.205-1.059-12%1.964-161%0.016-7784%0.016-7784%
Book Value Per Share--0.2042.399-91%2.679-92%1.455-86%1.455-86%
Current Ratio--1.0171.544-34%3.174-68%2.751-63%2.751-63%
Debt To Asset Ratio--0.9700.727+33%0.711+36%0.806+20%0.806+20%
Debt To Equity Ratio--31.8559.659+230%2.734+1065%4.297+641%4.297+641%
Dividend Per Share----0%-0%-0%-0%
Eps---1.246-1.415+14%-0.107-91%-0.888-29%-0.888-29%
Free Cash Flow Per Share---0.394-1.194+203%-1.626+313%-0.977+148%-0.977+148%
Free Cash Flow To Equity Per Share---0.278-1.518+447%1.857-115%0.055-604%0.055-604%
Gross Profit Margin--1.0121.058-4%1.006+1%1.020-1%1.020-1%
Intrinsic Value_10Y_max---48.767--------
Intrinsic Value_10Y_min---41.998--------
Intrinsic Value_1Y_max---4.287--------
Intrinsic Value_1Y_min---4.211--------
Intrinsic Value_3Y_max---13.338--------
Intrinsic Value_3Y_min---12.724--------
Intrinsic Value_5Y_max---22.940--------
Intrinsic Value_5Y_min---21.253--------
Market Cap5852821.500-663%44634125.70013763036.993+224%40096407.720+11%16572136.835+169%16572136.835+169%
Net Profit Margin---0.714-0.882+23%-0.543-24%-0.900+26%-0.900+26%
Operating Margin---0.549-0.794+45%-1.055+92%-0.957+74%-0.957+74%
Operating Ratio--1.5221.792-15%2.189-30%2.012-24%2.012-24%
Pb Ratio5.639-663%43.00010.937+293%3.406+1162%4.413+874%4.413+874%
Pe Ratio-0.231+87%-1.759-0.581-67%-1.190-32%-0.545-69%-0.545-69%
Price Per Share1.150-663%8.7702.704+224%3.440+155%1.891+364%1.891+364%
Price To Free Cash Flow Ratio-0.730+87%-5.568-1.496-73%5.805-196%1.326-520%1.326-520%
Price To Total Gains Ratio-0.954+87%-7.275-1.088-85%1.644-543%0.278-2719%0.278-2719%
Quick Ratio--0.5701.359-58%1.936-71%1.423-60%1.423-60%
Return On Assets---0.186-0.171-8%-0.115-38%-0.196+5%-0.196+5%
Return On Equity---6.110-2.011-67%-0.566-91%-0.842-86%-0.842-86%
Total Gains Per Share---1.205-1.059-12%1.964-161%0.016-7784%0.016-7784%
Usd Book Value--1038000.00012210250.000-91%15626000.000-93%8019538.462-87%8019538.462-87%
Usd Book Value Change Per Share---1.205-1.059-12%1.964-161%0.016-7784%0.016-7784%
Usd Book Value Per Share--0.2042.399-91%2.679-92%1.455-86%1.455-86%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---1.246-1.415+14%-0.107-91%-0.888-29%-0.888-29%
Usd Free Cash Flow---2004000.000-6078750.000+203%-11961500.000+497%-6107769.231+205%-6107769.231+205%
Usd Free Cash Flow Per Share---0.394-1.194+203%-1.626+313%-0.977+148%-0.977+148%
Usd Free Cash Flow To Equity Per Share---0.278-1.518+447%1.857-115%0.055-604%0.055-604%
Usd Market Cap5852821.500-663%44634125.70013763036.993+224%40096407.720+11%16572136.835+169%16572136.835+169%
Usd Price Per Share1.150-663%8.7702.704+224%3.440+155%1.891+364%1.891+364%
Usd Profit---6342000.000-6610500.000+4%-6127500.000-3%-5948461.538-6%-5948461.538-6%
Usd Revenue--8879000.0008401000.000+6%6778750.000+31%6728923.077+32%6728923.077+32%
Usd Total Gains Per Share---1.205-1.059-12%1.964-161%0.016-7784%0.016-7784%
 EOD+3 -5MRQTTM+17 -17YOY+12 -225Y+13 -2110Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Biofrontera Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.231
Price to Book Ratio (EOD)Between0-15.639
Net Profit Margin (MRQ)Greater than0-0.714
Operating Margin (MRQ)Greater than0-0.549
Quick Ratio (MRQ)Greater than10.570
Current Ratio (MRQ)Greater than11.017
Debt to Asset Ratio (MRQ)Less than10.970
Debt to Equity Ratio (MRQ)Less than131.855
Return on Equity (MRQ)Greater than0.15-6.110
Return on Assets (MRQ)Greater than0.05-0.186
Total2/10 (20.0%)

4.3. Technical Score

Let's check the technical score of Biofrontera Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.267
Ma 20Greater thanMa 501.196
Ma 50Greater thanMa 1001.152
Ma 100Greater thanMa 2002.241
OpenGreater thanClose1.100
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets34,104
Total Liabilities33,066
Total Stockholder Equity1,038
 As reported
Total Liabilities 33,066
Total Stockholder Equity+ 1,038
Total Assets = 34,104

Assets

Total Assets34,104
Total Current Assets29,611
Long-term Assets4,493
Total Current Assets
Cash And Cash Equivalents 3,422
Short-term Investments 3,341
Net Receivables 6,506
Inventory 16,068
Other Current Assets 274
Total Current Assets  (as reported)29,611
Total Current Assets  (calculated)29,611
+/-0
Long-term Assets
Property Plant Equipment 1,283
Intangible Assets 2,718
Long-term Assets Other 492
Long-term Assets  (as reported)4,493
Long-term Assets  (calculated)4,493
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities29,124
Long-term Liabilities3,942
Total Stockholder Equity1,038
Total Current Liabilities
Short-term Debt 2,252
Short Long Term Debt 1,697
Accounts payable 8,622
Other Current Liabilities 11,039
Total Current Liabilities  (as reported)29,124
Total Current Liabilities  (calculated)23,610
+/- 5,514
Long-term Liabilities
Capital Lease Obligations 1,117
Long-term Liabilities Other 38
Long-term Liabilities  (as reported)3,942
Long-term Liabilities  (calculated)1,155
+/- 2,787
Total Stockholder Equity
Common Stock1
Retained Earnings -103,176
Other Stockholders Equity 104,213
Total Stockholder Equity (as reported)1,038
Total Stockholder Equity (calculated)1,038
+/-0
Other
Capital Stock1
Cash and Short Term Investments 6,763
Common Stock Shares Outstanding 1,367
Current Deferred Revenue7,211
Liabilities and Stockholders Equity 34,104
Net Debt -608
Net Invested Capital 2,735
Net Working Capital 487
Property Plant and Equipment Gross 1,283
Short Long Term Debt Total 2,814



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
24,138
0
17,695
15,354
53,219
53,219
53,626
55,059
50,884
41,965
36,905
34,104
34,10436,90541,96550,88455,05953,62653,21953,21915,35417,695024,1380
   > Total Current Assets 
19,576
19,576
16,102
12,730
10,137
46,421
46,421
46,981
48,493
43,140
37,223
32,296
29,611
29,61132,29637,22343,14048,49346,98146,42146,42110,13712,73016,10219,57619,576
       Cash And Cash Equivalents 
0
8,080
0
3,052
1,716
24,545
24,545
31,913
27,518
17,208
13,505
4,453
3,422
3,4224,45313,50517,20827,51831,91324,54524,5451,7163,05208,0800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
10,548
7,596
5,935
3,341
3,3415,9357,59610,548000000000
       Net Receivables 
3,289
3,289
1,910
1,783
2,046
7,042
12,431
5,046
8,082
7,406
7,866
6,194
6,506
6,5066,1947,8667,4068,0825,04612,4317,0422,0461,7831,9103,2893,289
       Inventory 
7,091
7,091
8,425
6,719
5,439
4,458
4,458
8,808
12,087
7,168
6,670
14,785
16,068
16,06814,7856,6707,16812,0878,8084,4584,4585,4396,7198,4257,0917,091
       Other Current Assets 
619
498
571
488
425
9,552
4,987
487
261
810
1,586
929
274
2749291,5868102614874,9879,552425488571498619
   > Long-term Assets 
0
4,562
0
4,965
5,217
6,798
6,798
6,645
6,566
7,744
4,742
4,609
4,493
4,4934,6094,7427,7446,5666,6456,7986,7985,2174,96504,5620
       Property Plant Equipment 
370
370
334
314
289
267
267
248
224
1,579
1,431
1,282
1,283
1,2831,2821,4311,579224248267267289314334370370
       Intangible Assets 
0
3,869
0
3,659
3,555
3,450
3,450
3,241
3,136
3,032
2,927
2,823
2,718
2,7182,8232,9273,0323,1363,2413,4503,4503,5553,65903,8690
       Long-term Assets Other 
0
323
0
992
1,373
268
3,081
3,156
3,206
3,133
384
504
492
4925043843,1333,2063,1563,0812681,37399203230
> Total Liabilities 
0
18,310
0
19,062
32,734
41,881
41,881
36,393
32,464
27,005
25,214
29,732
33,066
33,06629,73225,21427,00532,46436,39341,88141,88132,73419,062018,3100
   > Total Current Liabilities 
4,420
4,420
4,050
4,031
11,291
13,836
13,836
14,876
17,143
20,894
20,450
25,352
29,124
29,12425,35220,45020,89417,14314,87613,83613,83611,2914,0314,0504,4204,420
       Short-term Debt 
0
0
0
0
0
0
6,694
0
0
498
484
1,595
2,252
2,2521,595484498006,694000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
1,106
1,697
1,6971,10600000000000
       Accounts payable 
1,414
176
615
208
367
740
658
2,221
4,459
1,278
1,799
5,900
8,622
8,6225,9001,7991,2784,4592,2216587403672086151761,414
       Other Current Liabilities 
569
4,244
1,182
3,823
10,924
9,696
3,242
9,413
9,442
12,176
11,135
10,736
11,039
11,03910,73611,13512,1769,4429,4133,2429,69610,9243,8231,1824,244569
   > Long-term Liabilities 
0
13,890
0
15,031
21,443
28,045
28,045
21,517
15,321
6,111
4,764
4,380
3,942
3,9424,3804,7646,11115,32121,51728,04528,04521,44315,031013,8900
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
-6,694
0
0
848
725
-506
-1,135
-1,135-50672584800-6,694000000
       Long-term Liabilities Other 
0
62
0
26
21,443
5,649
15,284
13,471
11,357
21
24
40
38
3840242111,35713,47115,2845,64921,443260620
       Deferred Long Term Liability 
0
0
300
724
0
0
0
0
0
0
0
0
0
00000000072430000
> Total Stockholder Equity
0
5,828
0
-1,367
-17,380
11,338
11,338
17,233
22,595
23,879
16,751
7,173
1,038
1,0387,17316,75123,87922,59517,23311,33811,338-17,380-1,36705,8280
   Common Stock
8
8
8
8
8
17
17
19
23
27
27
27
1
12727272319171788888
   Retained Earnings Total Equity0000000000000
   Accumulated Other Comprehensive Income 0000000000000
   Capital Surplus 0000000000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
46,986
0
46,986
46,986
0
90,200
91,382
99,306
103,370
103,721
103,980
104,213
104,213103,980103,721103,37099,30691,38290,200046,98646,986046,9860



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue33,619
Cost of Revenue-17,332
Gross Profit16,28716,287
 
Operating Income (+$)
Gross Profit16,287
Operating Expense-57,651
Operating Income-24,032-41,364
 
Operating Expense (+$)
Research Development-
Selling General Administrative40,275
Selling And Marketing Expenses-
Operating Expense57,65140,275
 
Net Interest Income (+$)
Interest Income168
Interest Expense-459
Other Finance Cost-0
Net Interest Income-291
 
Pretax Income (+$)
Operating Income-24,032
Net Interest Income-291
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-26,421-21,934
EBIT - interestExpense = -459
-26,442
-25,983
Interest Expense459
Earnings Before Interest and Taxes (EBIT)--25,962
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-26,421
Tax Provision-21
Net Income From Continuing Ops-26,442-26,442
Net Income-26,442
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,098291
 

Technical Analysis of Biofrontera Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biofrontera Inc. The general trend of Biofrontera Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biofrontera Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biofrontera Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.88 < 1.95 < 2.66.

The bearish price targets are: 1.02 > 0.761 > 0.61.

Tweet this
Biofrontera Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biofrontera Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biofrontera Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biofrontera Inc. The current macd is 0.00411373.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biofrontera Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biofrontera Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biofrontera Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biofrontera Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiofrontera Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biofrontera Inc. The current adx is 22.01.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biofrontera Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Biofrontera Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biofrontera Inc. The current sar is 1.93284.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biofrontera Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biofrontera Inc. The current rsi is 47.27. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Biofrontera Inc Daily Relative Strength Index (RSI) ChartBiofrontera Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biofrontera Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biofrontera Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biofrontera Inc Daily Stochastic Oscillator ChartBiofrontera Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biofrontera Inc. The current cci is -26.39184758.

Biofrontera Inc Daily Commodity Channel Index (CCI) ChartBiofrontera Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biofrontera Inc. The current cmo is -7.93040724.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biofrontera Inc Daily Chande Momentum Oscillator (CMO) ChartBiofrontera Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biofrontera Inc. The current willr is -86.02150538.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Biofrontera Inc Daily Williams %R ChartBiofrontera Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biofrontera Inc.

Biofrontera Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biofrontera Inc. The current atr is 0.18226793.

Biofrontera Inc Daily Average True Range (ATR) ChartBiofrontera Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biofrontera Inc. The current obv is 24,826,657.

Biofrontera Inc Daily On-Balance Volume (OBV) ChartBiofrontera Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biofrontera Inc. The current mfi is 58.74.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biofrontera Inc Daily Money Flow Index (MFI) ChartBiofrontera Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biofrontera Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-11-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Biofrontera Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biofrontera Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.267
Ma 20Greater thanMa 501.196
Ma 50Greater thanMa 1001.152
Ma 100Greater thanMa 2002.241
OpenGreater thanClose1.100
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biofrontera Inc with someone you think should read this too:
  • Are you bullish or bearish on Biofrontera Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biofrontera Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biofrontera Inc

I send you an email if I find something interesting about Biofrontera Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biofrontera Inc.

Receive notifications about Biofrontera Inc in your mailbox!